![](https://www.clinicaltrialsarena.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
HLA-class-II/Factor VIII (FVIII) Peptidomic Variation in Dendritic Cells
By Cellular Technology LimitedPlasma-derived (pd) or recombinant (r) therapeutic factor VIII proteins (FVIIIs) are infused to arrest/prevent bleeding in patients with hemophilia A (PWHA). However,...
Read more
![](https://www.clinicaltrialsarena.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)